Supernus SUPN Stock
Supernus Price Chart
Supernus SUPN Financial and Trading Overview
| Supernus stock price | 28.8 USD |
| Previous Close | 28.83 USD |
| Open | 28.72 USD |
| Bid | 29.22 USD x 100 |
| Ask | 28.81 USD x 100 |
| Day's Range | 28.46 - 29.69 USD |
| 52 Week Range | 25.92 - 42.81 USD |
| Volume | 2.81M USD |
| Avg. Volume | 2.74M USD |
| Market Cap | 6.03B USD |
| Beta (5Y Monthly) | 1.132 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.76 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 54.14 USD |
SUPN Valuation Measures
| Enterprise Value | 3.62B USD |
| Trailing P/E | N/A |
| Forward P/E | 7.253345 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.390326 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.637 |
| Enterprise Value/EBITDA | 5.558 |
Trading Information
Supernus Stock Price History
| Beta (5Y Monthly) | 1.132 |
| 52-Week Change | -10.92% |
| S&P500 52-Week Change | 10.51% |
| 52 Week High | 42.81 USD |
| 52 Week Low | 25.92 USD |
| 50-Day Moving Average | 33.69 USD |
| 200-Day Moving Average | 35.37 USD |
SUPN Share Statistics
| Avg. Volume (3 month) | 2.74M USD |
| Avg. Daily Volume (10-Days) | 4.18M USD |
| Shares Outstanding | 207.72M |
| Float | 114.74M |
| Short Ratio | 4.26 |
| % Held by Insiders | 2.06% |
| % Held by Institutions | 61.21% |
| Shares Short | 4.62M |
| Short % of Float | 9.72% |
| Short % of Shares Outstanding | 7.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 32.75% |
| Operating Margin (ttm) | 46.94% |
| Gross Margin | 85.73% |
| EBITDA Margin | 47.45% |
Management Effectiveness
| Return on Assets (ttm) | 29.33% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.37B USD |
| Revenue Per Share (ttm) | 11.26 USD |
| Quarterly Revenue Growth (yoy) | 13.40% |
| Gross Profit (ttm) | 1.18B USD |
| EBITDA | 652M USD |
| Net Income Avi to Common (ttm) | 450M USD |
| Diluted EPS (ttm) | -0.76 |
| Quarterly Earnings Growth (yoy) | 226.19% |
Balance Sheet
| Total Cash (mrq) | 305M USD |
| Total Cash Per Share (mrq) | 2.58 USD |
| Total Debt (mrq) | 501M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.615 |
| Book Value Per Share (mrq) | -0.508 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 96M USD |
| Levered Free Cash Flow (ttm) | 227.12M USD |
Profile of Supernus
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 9715 Key West Avenue |
| ZIP | 20850 |
| Phone | 301 838 2500 |
| Website | https://www.supernus.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 827 |
Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.
Q&A For Supernus Stock
What is a current SUPN stock price?
Supernus SUPN stock price today per share is 28.8 USD.
How to purchase Supernus stock?
You can buy SUPN shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Supernus?
The stock symbol or ticker of Supernus is SUPN.
Which industry does the Supernus company belong to?
The Supernus industry is Drug Manufacturers - Specialty & Generic.
How many shares does Supernus have in circulation?
The max supply of Supernus shares is 207.72M.
What is Supernus Price to Earnings Ratio (PE Ratio)?
Supernus PE Ratio is now.
What was Supernus earnings per share over the trailing 12 months (TTM)?
Supernus EPS is -0.76 USD over the trailing 12 months.
Which sector does the Supernus company belong to?
The Supernus sector is Healthcare.
Supernus SUPN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
24356.87 USD — |
+0.12
|
2.55B USD — | 24268.03 USD — | 24538.78 USD — | — - | 2.55B USD — |
US Tech Composite Total Return
XCMP
US
|
30153.42 USD — |
+0.3
|
— — | 29990.36 USD — | 30324.94 USD — | — - | — — |
US Tech US 700 Small Cap Value I
NQUS700SCV
US
|
2649.53 USD — |
+0.46
|
— — | 2625.83 USD — | 2654.08 USD — | — - | — — |
US Tech Global Market Composite
NQGM
US
|
1839.09 USD — |
+0.18
|
— — | 1832.56 USD — | 1855.92 USD — | — - | — — |
US Tech Biotechnology
NBI
US
|
6986.34 USD — |
-0.45
|
— — | 6959.96 USD — | 7076.43 USD — | — - | — — |
US Tech Health Care
IXHC
US
|
1327.34 USD — |
-0.42
|
— — | 1322.85 USD — | 1342.46 USD — | — - | — — |
US Tech Biotechnology Total Retu
XNBI
US
|
7645.1 USD — |
-0.3
|
— — | 7605.28 USD — | 7732.54 USD — | — - | — — |
US Tech US 700 Small Cap Value N
NQUS700SCVN
US
|
3048.73 USD — |
+0.46
|
— — | 3021.53 USD — | 3054.02 USD — | — - | — — |
US Tech US 700 Small Cap Index
NQUS700SC
US
|
2943.08 USD — |
+0.53
|
— — | 2921.79 USD — | 2953.86 USD — | — - | — — |
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |


